Literature DB >> 33544645

Epigenetic Remodeling in Innate Immunity and Inflammation.

Qian Zhang1,2, Xuetao Cao1,2,3.   

Abstract

The innate immune response is a rapid response to pathogens or danger signals. It is precisely activated not only to efficiently eliminate pathogens but also to avoid excessive inflammation and tissue damage. cis-Regulatory element-associated chromatin architecture shaped by epigenetic factors, which we define as the epiregulome, endows innate immune cells with specialized phenotypes and unique functions by establishing cell-specific gene expression patterns, and it also contributes to resolution of the inflammatory response. In this review, we focus on two aspects: (a) how niche signals during lineage commitment or following infection and pathogenic stress program epiregulomes by regulating gene expression levels, enzymatic activities, or gene-specific targeting of chromatin modifiers and (b) how the programed epiregulomes in turn mediate regulation of gene-specific expression, which contributes to controlling the development of innate cells, or the response to infection and inflammation, in a timely manner. We also discuss the effects of innate immunometabolic rewiring on epiregulomes and speculate on several future challenges to be encountered during the exploration of the master regulators of epiregulomes in innate immunity and inflammation.

Entities:  

Keywords:  chromatin modifier; dendritic cell; epiregulome; immune memory; innate immunity; macrophage; metabolite

Year:  2021        PMID: 33544645     DOI: 10.1146/annurev-immunol-093019-123619

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  14 in total

Review 1.  Epigenetic regulation of natural killer cell memory.

Authors:  Colleen M Lau; Gabriela M Wiedemann; Joseph C Sun
Journal:  Immunol Rev       Date:  2021-12-14       Impact factor: 12.988

Review 2.  NLRP3 Inflammasome in Atherosclerosis: Putting Out the Fire of Inflammation.

Authors:  Bo-Zong Shao; Hai-Yan Xu; Yi-Cheng Zhao; Xiao-Rui Zheng; Fang Wang; Guan-Ren Zhao
Journal:  Inflammation       Date:  2022-08-11       Impact factor: 4.657

Review 3.  Effects of Anthraquinones on Immune Responses and Inflammatory Diseases.

Authors:  Dandan Xin; Huhu Li; Shiyue Zhou; Hao Zhong; Weiling Pu
Journal:  Molecules       Date:  2022-06-14       Impact factor: 4.927

Review 4.  Modulation of the Response to Mycobacterium leprae and Pathogenesis of Leprosy.

Authors:  Natasha Cabral; Vilma de Figueiredo; Mariana Gandini; Cíntia Fernandes de Souza; Rychelle Affonso Medeiros; Letícia Miranda Santos Lery; Flávio Alves Lara; Cristiana Santos de Macedo; Maria Cristina Vidal Pessolani; Geraldo Moura Batista Pereira
Journal:  Front Microbiol       Date:  2022-06-02       Impact factor: 6.064

5.  m6A demethylase ALKBH5 is required for antibacterial innate defense by intrinsic motivation of neutrophil migration.

Authors:  Yang Liu; Renjie Song; Lu Zhao; Zhike Lu; Yini Li; Xinyi Zhan; Fengjiao Lu; Jiang Yang; Yamei Niu; Xuetao Cao
Journal:  Signal Transduct Target Ther       Date:  2022-06-29

6.  Targeting epigenetic modifiers to reprogramme macrophages in non-resolving inflammation-driven atherosclerosis.

Authors:  Fengyan Jin; Jian Li; Jianfeng Guo; Thorsten R Doeppner; Dirk M Hermann; Gang Yao; Yun Dai
Journal:  Eur Heart J Open       Date:  2021-08-17

Review 7.  Epigenetic modulation of antitumor immunity for improved cancer immunotherapy.

Authors:  Enyong Dai; Zhi Zhu; Shudipto Wahed; Zhaoxia Qu; Walter J Storkus; Zong Sheng Guo
Journal:  Mol Cancer       Date:  2021-12-20       Impact factor: 41.444

8.  Epigenetic checkpoint blockade: new booster for immunotherapy.

Authors:  Ziqiao Wang; Bingjing Wang; Xuetao Cao
Journal:  Signal Transduct Target Ther       Date:  2021-07-22

Review 9.  Emerging Roles of MHC Class I Region-Encoded E3 Ubiquitin Ligases in Innate Immunity.

Authors:  Xiuzhi Jia; Chunyuan Zhao; Wei Zhao
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

Review 10.  Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic Potential.

Authors:  Ya-Nan Pi; Wen-Cai Qi; Bai-Rong Xia; Ge Lou; Wei-Lin Jin
Journal:  Front Immunol       Date:  2021-07-06       Impact factor: 8.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.